XORTX Therapeutics Inc. Made Big Gain
Fri, Sep 23, 2022 at 07:30 PM
XORTX Therapeutics Inc. (XRTX:NASDAQ) soared at $1.21, a gain of 28.8%. The stock got featured on our News Catalysts scanner on Mon, Sep 19, 2022 at 07:59 AM in the 'MISCELLANEOUS' category. From Fri, Sep 09, 2022, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Wed, Jul 13, 2022 at $2.23 with a volume of 23M+.
About XORTX Therapeutics Inc. (XRTX:NASDAQ)
XORTX Therapeutics Inc is focused on developing drug therapies for orphan disease like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which...
Top 10 Gainers:
- Golden Sun Education Group Limited (GSUN:NASDAQ), 92.05%
- Kiromic BioPharma Inc. (KRBP:NASDAQ), 46.43%
- Athersys, Inc. (ATHX:NASDAQ), 39.32%
- Snow Lake Resources Ltd. (LITM:NASDAQ), 38.26%
- Global Cord Blood Corporation (CO:NYSE), 34.58%
- Vertical Aerospace Ltd. (EVTL:NYSE), 32.06%
- Sonendo Inc. (SONX:NYSE), 30.08%
- XORTX Therapeutics Inc. (XRTX:NASDAQ), 28.75%
- Evaxion Biotech A/S (EVAX:NASDAQ), 19.75%
- Trio-Tech International (TRT:NYSEMKT), 19.61%